Gene Symbol | Gene ID | Gene Info |
---|---|---|
YBX1
|
ENSG00000065978.13 | Y-box binding protein 1 |
FOS
|
ENSG00000170345.5 | Fos proto-oncogene, AP-1 transcription factor subunit |
NFYC
|
ENSG00000066136.15 | nuclear transcription factor Y subunit gamma |
NFYA
|
ENSG00000001167.10 | nuclear transcription factor Y subunit alpha |
NFYB
|
ENSG00000120837.3 | nuclear transcription factor Y subunit beta |
CEBPZ
|
ENSG00000115816.9 | CCAAT enhancer binding protein zeta |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_37458120_37458800 | CEBPZ | 52 | 0.824783 | 0.59 | 9.6e-02 | Click! |
chr2_37457469_37457620 | CEBPZ | 968 | 0.368500 | -0.01 | 9.9e-01 | Click! |
chr14_75800702_75800905 | FOS | 53907 | 0.102622 | 0.95 | 8.4e-05 | Click! |
chr14_75807662_75807918 | FOS | 60894 | 0.091711 | 0.88 | 2.0e-03 | Click! |
chr14_75800906_75801057 | FOS | 54085 | 0.102335 | 0.76 | 1.7e-02 | Click! |
chr14_75799363_75799514 | FOS | 52542 | 0.104829 | 0.76 | 1.9e-02 | Click! |
chr14_75777737_75777888 | FOS | 30916 | 0.140396 | -0.75 | 2.0e-02 | Click! |
chr6_41048535_41048765 | NFYA | 7928 | 0.125693 | 0.86 | 3.2e-03 | Click! |
chr6_41041590_41042059 | NFYA | 1102 | 0.330807 | 0.50 | 1.7e-01 | Click! |
chr6_41042589_41042740 | NFYA | 1942 | 0.211503 | -0.47 | 2.0e-01 | Click! |
chr6_41042761_41042912 | NFYA | 2114 | 0.199427 | -0.41 | 2.8e-01 | Click! |
chr6_41048014_41048165 | NFYA | 7367 | 0.126961 | 0.36 | 3.4e-01 | Click! |
chr12_104529921_104530072 | NFYB | 1799 | 0.333155 | -0.69 | 4.0e-02 | Click! |
chr12_104529003_104529154 | NFYB | 2717 | 0.251281 | -0.47 | 2.1e-01 | Click! |
chr12_104528842_104528993 | NFYB | 2878 | 0.243288 | -0.18 | 6.5e-01 | Click! |
chr12_104531475_104531655 | NFYB | 230 | 0.927610 | 0.17 | 6.6e-01 | Click! |
chr12_104530541_104531294 | NFYB | 878 | 0.584262 | 0.15 | 7.0e-01 | Click! |
chr1_41176173_41176466 | NFYC | 1104 | 0.436064 | -0.78 | 1.4e-02 | Click! |
chr1_41177230_41177555 | NFYC | 2177 | 0.245282 | -0.61 | 8.0e-02 | Click! |
chr1_41201683_41201834 | NFYC | 771 | 0.564162 | -0.57 | 1.1e-01 | Click! |
chr1_41201225_41201376 | NFYC | 313 | 0.857030 | -0.49 | 1.8e-01 | Click! |
chr1_41176755_41176906 | NFYC | 1615 | 0.311834 | -0.48 | 1.9e-01 | Click! |
chr1_43152583_43152734 | YBX1 | 4000 | 0.196747 | -0.75 | 1.9e-02 | Click! |
chr1_43148002_43148191 | YBX1 | 2 | 0.974925 | 0.68 | 4.4e-02 | Click! |
chr1_43147265_43147870 | YBX1 | 531 | 0.753513 | 0.59 | 9.5e-02 | Click! |
chr1_43151193_43151344 | YBX1 | 2610 | 0.241868 | -0.58 | 1.0e-01 | Click! |
chr1_43150005_43150156 | YBX1 | 1422 | 0.381741 | -0.55 | 1.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_185826921_185827162 | 6.78 |
ETV5 |
ets variant 5 |
140 |
0.97 |
chr17_74261054_74261205 | 4.76 |
UBALD2 |
UBA-like domain containing 2 |
154 |
0.93 |
chr20_3389349_3389676 | 3.37 |
C20orf194 |
chromosome 20 open reading frame 194 |
1240 |
0.39 |
chr3_42003803_42004029 | 3.20 |
ULK4 |
unc-51 like kinase 4 |
6 |
0.98 |
chr1_160616525_160616783 | 2.81 |
SLAMF1 |
signaling lymphocytic activation molecule family member 1 |
157 |
0.95 |
chr19_11546030_11546251 | 2.80 |
PRKCSH |
protein kinase C substrate 80K-H |
31 |
0.69 |
chr5_95152547_95152698 | 2.80 |
GLRX |
glutaredoxin (thioltransferase) |
5793 |
0.16 |
chr19_1041079_1041435 | 2.77 |
ABCA7 |
ATP-binding cassette, sub-family A (ABC1), member 7 |
56 |
0.93 |
chr19_14247522_14247677 | 2.74 |
ASF1B |
anti-silencing function 1B histone chaperone |
169 |
0.72 |
chr10_11206567_11206809 | 2.61 |
CELF2 |
CUGBP, Elav-like family member 2 |
305 |
0.91 |
chr12_53773389_53773606 | 2.60 |
SP1 |
Sp1 transcription factor |
463 |
0.73 |
chr2_198173822_198174153 | 2.56 |
ANKRD44 |
ankyrin repeat domain 44 |
1524 |
0.32 |
chr15_70827822_70828052 | 2.55 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
166683 |
0.04 |
chr4_7044727_7044878 | 2.53 |
CCDC96 |
coiled-coil domain containing 96 |
74 |
0.78 |
chr1_9910319_9910542 | 2.52 |
RP11-84A14.5 |
|
2054 |
0.27 |
chr1_166459489_166459697 | 2.46 |
FAM78B |
family with sequence similarity 78, member B |
323387 |
0.01 |
chr10_102133099_102133250 | 2.46 |
ENSG00000212325 |
. |
25029 |
0.12 |
chr5_149789396_149789547 | 2.44 |
CD74 |
CD74 molecule, major histocompatibility complex, class II invariant chain |
2824 |
0.24 |
chr1_154984608_154984759 | 2.36 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
2241 |
0.12 |
chr12_51818248_51818602 | 2.35 |
RP11-607P23.1 |
|
30 |
0.62 |
chr14_105531321_105531563 | 2.33 |
GPR132 |
G protein-coupled receptor 132 |
325 |
0.89 |
chr5_134731392_134731690 | 2.31 |
H2AFY |
H2A histone family, member Y |
3360 |
0.2 |
chr18_13465441_13465744 | 2.28 |
LDLRAD4 |
low density lipoprotein receptor class A domain containing 4 |
578 |
0.59 |
chr3_119813893_119814044 | 2.23 |
GSK3B |
glycogen synthase kinase 3 beta |
704 |
0.69 |
chr7_150436038_150436258 | 2.17 |
GIMAP5 |
GTPase, IMAP family member 5 |
1712 |
0.32 |
chr6_41906749_41907033 | 2.13 |
CCND3 |
cyclin D3 |
1573 |
0.29 |
chrX_47510164_47510912 | 2.11 |
ELK1 |
ELK1, member of ETS oncogene family |
535 |
0.67 |
chr20_62708665_62709256 | 2.10 |
RGS19 |
regulator of G-protein signaling 19 |
1885 |
0.17 |
chr10_103879275_103879554 | 2.08 |
LDB1 |
LIM domain binding 1 |
796 |
0.54 |
chr11_60739721_60739997 | 2.04 |
CD6 |
CD6 molecule |
521 |
0.66 |
chr14_22538566_22539116 | 2.04 |
ENSG00000238634 |
. |
72046 |
0.12 |
chr16_68771052_68771203 | 2.03 |
CDH1 |
cadherin 1, type 1, E-cadherin (epithelial) |
1 |
0.97 |
chr19_14228526_14228677 | 2.01 |
PRKACA |
protein kinase, cAMP-dependent, catalytic, alpha |
45 |
0.94 |
chr19_2084975_2085126 | 1.98 |
MOB3A |
MOB kinase activator 3A |
341 |
0.8 |
chr16_2955962_2956164 | 1.96 |
FLYWCH1 |
FLYWCH-type zinc finger 1 |
5875 |
0.1 |
chr12_122240931_122241144 | 1.92 |
RHOF |
ras homolog family member F (in filopodia) |
203 |
0.88 |
chr22_24181254_24181487 | 1.91 |
DERL3 |
derlin 3 |
171 |
0.9 |
chr1_182360957_182361120 | 1.87 |
GLUL |
glutamate-ammonia ligase |
111 |
0.97 |
chr12_54752952_54753103 | 1.85 |
GPR84 |
G protein-coupled receptor 84 |
5231 |
0.09 |
chr19_42784634_42784952 | 1.85 |
CIC |
capicua transcriptional repressor |
3379 |
0.11 |
chr2_160761281_160761780 | 1.83 |
LY75-CD302 |
LY75-CD302 readthrough |
309 |
0.48 |
chr19_13906051_13906257 | 1.77 |
ZSWIM4 |
zinc finger, SWIM-type containing 4 |
120 |
0.9 |
chr9_99180680_99180947 | 1.77 |
ZNF367 |
zinc finger protein 367 |
202 |
0.95 |
chr20_4802726_4803481 | 1.73 |
RASSF2 |
Ras association (RalGDS/AF-6) domain family member 2 |
1188 |
0.5 |
chr5_163343617_163343778 | 1.72 |
ENSG00000251998 |
. |
120526 |
0.07 |
chr19_49164249_49164514 | 1.71 |
NTN5 |
netrin 5 |
11883 |
0.08 |
chr1_169863342_169863522 | 1.70 |
SCYL3 |
SCY1-like 3 (S. cerevisiae) |
24 |
0.98 |
chr3_47830681_47830832 | 1.70 |
SMARCC1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
7349 |
0.17 |
chrX_77581417_77581703 | 1.70 |
CYSLTR1 |
cysteinyl leukotriene receptor 1 |
1420 |
0.59 |
chr14_86400709_86400890 | 1.70 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
404227 |
0.01 |
chr11_46370356_46370605 | 1.70 |
DGKZ |
diacylglycerol kinase, zeta |
1342 |
0.36 |
chrX_48776392_48776920 | 1.69 |
PIM2 |
pim-2 oncogene |
355 |
0.76 |
chr12_56617809_56618059 | 1.68 |
NABP2 |
nucleic acid binding protein 2 |
175 |
0.85 |
chr12_54610003_54610573 | 1.66 |
ENSG00000265371 |
. |
14972 |
0.1 |
chr1_46598683_46599066 | 1.65 |
PIK3R3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
166 |
0.92 |
chr19_1490936_1491166 | 1.65 |
REEP6 |
receptor accessory protein 6 |
114 |
0.84 |
chr16_3054073_3054278 | 1.63 |
LA16c-380H5.2 |
|
927 |
0.27 |
chr12_56727723_56727874 | 1.62 |
PAN2 |
PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae) |
8 |
0.94 |
chr19_40459552_40459703 | 1.60 |
PSMC4 |
proteasome (prosome, macropain) 26S subunit, ATPase, 4 |
17285 |
0.14 |
chr15_44116988_44117284 | 1.60 |
MFAP1 |
microfibrillar-associated protein 1 |
136 |
0.91 |
chr19_17377966_17378117 | 1.60 |
BABAM1 |
BRISC and BRCA1 A complex member 1 |
118 |
0.9 |
chr17_29647426_29647676 | 1.60 |
EVI2A |
ecotropic viral integration site 2A |
499 |
0.67 |
chr1_110881517_110881734 | 1.60 |
RP5-1074L1.1 |
|
168 |
0.68 |
chr6_26251322_26251789 | 1.59 |
HIST1H2BH |
histone cluster 1, H2bh |
324 |
0.6 |
chr1_19234602_19234753 | 1.59 |
IFFO2 |
intermediate filament family orphan 2 |
3809 |
0.18 |
chr9_84304698_84304897 | 1.57 |
TLE1 |
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) |
577 |
0.81 |
chr1_54954076_54954323 | 1.56 |
ENSG00000265404 |
. |
16142 |
0.18 |
chr9_37465575_37465786 | 1.53 |
ZBTB5 |
zinc finger and BTB domain containing 5 |
284 |
0.88 |
chr17_19015939_19016273 | 1.52 |
ENSG00000262202 |
. |
157 |
0.9 |
chr6_31795426_31795577 | 1.51 |
HSPA1B |
heat shock 70kDa protein 1B |
11 |
0.91 |
chr8_25315969_25316120 | 1.51 |
KCTD9 |
potassium channel tetramerization domain containing 9 |
61 |
0.88 |
chr19_4342924_4343143 | 1.50 |
MPND |
MPN domain containing |
491 |
0.57 |
chr9_131487099_131487303 | 1.49 |
RP11-545E17.3 |
|
477 |
0.53 |
chrX_65236705_65236856 | 1.48 |
ENSG00000207939 |
. |
1932 |
0.35 |
chr1_169674209_169674534 | 1.48 |
SELL |
selectin L |
6468 |
0.21 |
chr1_25291677_25291828 | 1.48 |
RUNX3 |
runt-related transcription factor 3 |
251 |
0.93 |
chr17_19091011_19091355 | 1.47 |
ENSG00000263934 |
. |
146 |
0.9 |
chr3_193853660_193853970 | 1.47 |
HES1 |
hes family bHLH transcription factor 1 |
119 |
0.96 |
chr19_41076676_41076827 | 1.46 |
SHKBP1 |
SH3KBP1 binding protein 1 |
6006 |
0.15 |
chr17_18964908_18965219 | 1.46 |
ENSG00000265185 |
. |
162 |
0.91 |
chr17_19093552_19093880 | 1.46 |
ENSG00000264940 |
. |
158 |
0.9 |
chr19_19174446_19174698 | 1.46 |
SLC25A42 |
solute carrier family 25, member 42 |
236 |
0.89 |
chr20_17549815_17549966 | 1.45 |
BFSP1 |
beaded filament structural protein 1, filensin |
25 |
0.92 |
chr1_19544624_19544775 | 1.45 |
EMC1 |
ER membrane protein complex subunit 1 |
5301 |
0.14 |
chr12_47754791_47755315 | 1.44 |
ENSG00000264906 |
. |
2999 |
0.29 |
chr12_9102320_9102555 | 1.44 |
M6PR |
mannose-6-phosphate receptor (cation dependent) |
106 |
0.64 |
chr2_64833990_64834366 | 1.44 |
ENSG00000252414 |
. |
28152 |
0.18 |
chr13_71865361_71865710 | 1.43 |
DACH1 |
dachshund homolog 1 (Drosophila) |
575372 |
0.0 |
chr21_47648763_47648914 | 1.42 |
LSS |
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) |
100 |
0.73 |
chrY_1730510_1730661 | 1.42 |
ENSG00000251841 |
. |
922205 |
0.0 |
chr17_18967446_18967725 | 1.42 |
ENSG00000262074 |
. |
136 |
0.92 |
chr9_123476776_123477054 | 1.41 |
MEGF9 |
multiple EGF-like-domains 9 |
167 |
0.97 |
chr16_87350937_87351088 | 1.40 |
C16orf95 |
chromosome 16 open reading frame 95 |
10 |
0.58 |
chr3_112693608_112694254 | 1.39 |
CD200R1 |
CD200 receptor 1 |
6 |
0.97 |
chr6_32634425_32634576 | 1.38 |
HLA-DQB1 |
major histocompatibility complex, class II, DQ beta 1 |
29 |
0.97 |
chr4_84035760_84036001 | 1.38 |
PLAC8 |
placenta-specific 8 |
9 |
0.98 |
chr1_169555058_169555307 | 1.37 |
F5 |
coagulation factor V (proaccelerin, labile factor) |
537 |
0.81 |
chr7_5571391_5571891 | 1.36 |
ACTB |
actin, beta |
1301 |
0.32 |
chr2_74743393_74743723 | 1.36 |
TLX2 |
T-cell leukemia homeobox 2 |
1947 |
0.12 |
chr12_15112589_15112941 | 1.35 |
ARHGDIB |
Rho GDP dissociation inhibitor (GDI) beta |
1435 |
0.37 |
chrX_128914916_128915218 | 1.35 |
SASH3 |
SAM and SH3 domain containing 3 |
1107 |
0.52 |
chr9_134150778_134151758 | 1.35 |
FAM78A |
family with sequence similarity 78, member A |
666 |
0.69 |
chr12_14570821_14570972 | 1.35 |
ATF7IP |
activating transcription factor 7 interacting protein |
1049 |
0.62 |
chr19_1507776_1507927 | 1.35 |
ADAMTSL5 |
ADAMTS-like 5 |
256 |
0.64 |
chr4_78114724_78115069 | 1.34 |
CCNG2 |
cyclin G2 |
35317 |
0.18 |
chr1_161195567_161195718 | 1.34 |
TOMM40L |
translocase of outer mitochondrial membrane 40 homolog (yeast)-like |
151 |
0.85 |
chr10_120101830_120102206 | 1.34 |
FAM204A |
family with sequence similarity 204, member A |
186 |
0.97 |
chr4_154354394_154354673 | 1.34 |
KIAA0922 |
KIAA0922 |
32965 |
0.17 |
chr4_153600093_153601094 | 1.33 |
TMEM154 |
transmembrane protein 154 |
571 |
0.78 |
chrX_48541906_48542057 | 1.33 |
WAS |
Wiskott-Aldrich syndrome |
187 |
0.91 |
chr16_31106057_31106225 | 1.33 |
VKORC1 |
vitamin K epoxide reductase complex, subunit 1 |
60 |
0.52 |
chr20_32308179_32308487 | 1.33 |
PXMP4 |
peroxisomal membrane protein 4, 24kDa |
208 |
0.89 |
chr1_221052565_221052774 | 1.32 |
HLA-AS1 |
HLA antisense RNA 1 |
813 |
0.46 |
chr1_183558573_183558724 | 1.31 |
NCF2 |
neutrophil cytosolic factor 2 |
1068 |
0.54 |
chr8_18069358_18069509 | 1.31 |
NAT1 |
N-acetyltransferase 1 (arylamine N-acetyltransferase) |
298 |
0.94 |
chr4_37075132_37075283 | 1.30 |
ENSG00000264319 |
. |
168406 |
0.04 |
chr11_2292275_2292426 | 1.30 |
ASCL2 |
achaete-scute family bHLH transcription factor 2 |
168 |
0.93 |
chr2_128284101_128284461 | 1.30 |
IWS1 |
IWS1 homolog (S. cerevisiae) |
181 |
0.94 |
chr19_17957141_17957427 | 1.30 |
JAK3 |
Janus kinase 3 |
1542 |
0.26 |
chr1_112262966_112263117 | 1.29 |
FAM212B |
family with sequence similarity 212, member B |
18834 |
0.15 |
chr6_10528391_10528633 | 1.29 |
GCNT2 |
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) |
77 |
0.97 |
chr11_118118220_118118371 | 1.28 |
MPZL3 |
myelin protein zero-like 3 |
4767 |
0.15 |
chr20_57735638_57735965 | 1.28 |
ZNF831 |
zinc finger protein 831 |
30274 |
0.2 |
chr7_150149402_150149565 | 1.28 |
GIMAP8 |
GTPase, IMAP family member 8 |
1765 |
0.33 |
chr10_104005118_104005269 | 1.28 |
GBF1 |
golgi brefeldin A resistant guanine nucleotide exchange factor 1 |
96 |
0.95 |
chr1_26616579_26616742 | 1.27 |
SH3BGRL3 |
SH3 domain binding glutamic acid-rich protein like 3 |
10047 |
0.11 |
chrX_53123138_53123457 | 1.27 |
TSPYL2 |
TSPY-like 2 |
11734 |
0.17 |
chr11_124609713_124609879 | 1.26 |
NRGN |
neurogranin (protein kinase C substrate, RC3) |
54 |
0.95 |
chr19_23867672_23867823 | 1.26 |
ZNF675 |
zinc finger protein 675 |
1436 |
0.51 |
chr9_7936080_7936231 | 1.26 |
TMEM261 |
transmembrane protein 261 |
136088 |
0.06 |
chr11_125757371_125757522 | 1.26 |
HYLS1 |
hydrolethalus syndrome 1 |
231 |
0.9 |
chr2_8628153_8628374 | 1.25 |
AC011747.7 |
|
187633 |
0.03 |
chr15_40732907_40733058 | 1.24 |
BAHD1 |
bromo adjacent homology domain containing 1 |
429 |
0.7 |
chr6_31782974_31783205 | 1.24 |
HSPA1A |
heat shock 70kDa protein 1A |
202 |
0.5 |
chr1_12079188_12079363 | 1.24 |
MIIP |
migration and invasion inhibitory protein |
248 |
0.88 |
chr19_47760300_47760580 | 1.24 |
CCDC9 |
coiled-coil domain containing 9 |
349 |
0.83 |
chr9_273119_273416 | 1.24 |
DOCK8 |
dedicator of cytokinesis 8 |
197 |
0.59 |
chr17_76755164_76755483 | 1.23 |
CYTH1 |
cytohesin 1 |
22351 |
0.17 |
chr12_122250371_122250682 | 1.23 |
SETD1B |
SET domain containing 1B |
7888 |
0.15 |
chr5_68514057_68514286 | 1.23 |
MRPS36 |
mitochondrial ribosomal protein S36 |
512 |
0.71 |
chr2_175498105_175498391 | 1.22 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
1059 |
0.58 |
chr7_141675948_141676169 | 1.21 |
TAS2R38 |
taste receptor, type 2, member 38 |
2485 |
0.23 |
chr7_130080720_130080961 | 1.20 |
CEP41 |
centrosomal protein 41kDa |
4 |
0.97 |
chr7_50345819_50346403 | 1.20 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
1733 |
0.5 |
chrX_3632137_3632344 | 1.20 |
PRKX |
protein kinase, X-linked |
591 |
0.8 |
chr3_119880714_119880865 | 1.19 |
ENSG00000244139 |
. |
40033 |
0.13 |
chr7_38398302_38398591 | 1.19 |
AMPH |
amphiphysin |
104267 |
0.08 |
chr17_33640471_33640814 | 1.19 |
SLFN11 |
schlafen family member 11 |
39508 |
0.12 |
chr20_42350731_42350882 | 1.18 |
GTSF1L |
gametocyte specific factor 1-like |
4531 |
0.26 |
chr12_92538049_92538662 | 1.17 |
BTG1 |
B-cell translocation gene 1, anti-proliferative |
654 |
0.51 |
chr9_130461454_130462084 | 1.17 |
C9orf117 |
chromosome 9 open reading frame 117 |
7502 |
0.11 |
chr4_40205891_40206102 | 1.17 |
RHOH |
ras homolog family member H |
4032 |
0.26 |
chr16_16170769_16170920 | 1.16 |
ABCC1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
67131 |
0.11 |
chr7_2559326_2559509 | 1.16 |
LFNG |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
59 |
0.97 |
chr19_46272674_46272825 | 1.16 |
SIX5 |
SIX homeobox 5 |
265 |
0.73 |
chr10_106083791_106084156 | 1.15 |
ITPRIP |
inositol 1,4,5-trisphosphate receptor interacting protein |
4709 |
0.15 |
chr11_3013544_3013695 | 1.14 |
NAP1L4 |
nucleosome assembly protein 1-like 4 |
12 |
0.96 |
chr22_50353929_50354264 | 1.14 |
PIM3 |
pim-3 oncogene |
65 |
0.97 |
chr19_11266572_11266789 | 1.14 |
SPC24 |
SPC24, NDC80 kinetochore complex component |
196 |
0.92 |
chr6_24934972_24935145 | 1.14 |
FAM65B |
family with sequence similarity 65, member B |
1130 |
0.57 |
chr8_66863324_66863561 | 1.14 |
DNAJC5B |
DnaJ (Hsp40) homolog, subfamily C, member 5 beta |
70353 |
0.12 |
chr8_61880355_61880506 | 1.14 |
CLVS1 |
clavesin 1 |
89287 |
0.1 |
chr10_124913793_124914183 | 1.13 |
BUB3 |
BUB3 mitotic checkpoint protein |
57 |
0.97 |
chr3_63964903_63965338 | 1.13 |
ATXN7 |
ataxin 7 |
11700 |
0.14 |
chr21_30397042_30397297 | 1.12 |
RP1-100J12.1 |
|
42 |
0.64 |
chr16_90143420_90143809 | 1.11 |
PRDM7 |
PR domain containing 7 |
1276 |
0.39 |
chr3_119813576_119813768 | 1.11 |
GSK3B |
glycogen synthase kinase 3 beta |
408 |
0.85 |
chr1_160991063_160991508 | 1.11 |
F11R |
F11 receptor |
147 |
0.92 |
chr11_73694420_73694811 | 1.11 |
UCP2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
263 |
0.89 |
chr14_99702038_99702570 | 1.10 |
AL109767.1 |
|
26981 |
0.19 |
chr9_93564472_93565060 | 1.10 |
SYK |
spleen tyrosine kinase |
557 |
0.87 |
chr5_39197523_39197702 | 1.10 |
FYB |
FYN binding protein |
5517 |
0.3 |
chr20_31407426_31407588 | 1.10 |
MAPRE1 |
microtubule-associated protein, RP/EB family, member 1 |
192 |
0.94 |
chr1_160674996_160675147 | 1.09 |
CD48 |
CD48 molecule |
6522 |
0.17 |
chr19_8454955_8455199 | 1.09 |
RAB11B |
RAB11B, member RAS oncogene family |
6 |
0.52 |
chr1_207095439_207095590 | 1.09 |
FAIM3 |
Fas apoptotic inhibitory molecule 3 |
171 |
0.94 |
chr2_102333626_102333777 | 1.08 |
MAP4K4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
18709 |
0.28 |
chr5_36242231_36242693 | 1.08 |
NADK2 |
NAD kinase 2, mitochondrial |
81 |
0.97 |
chr2_62931956_62932649 | 1.08 |
EHBP1 |
EH domain binding protein 1 |
485 |
0.83 |
chr15_75932752_75933121 | 1.08 |
IMP3 |
IMP3, U3 small nucleolar ribonucleoprotein, homolog (yeast) |
384 |
0.73 |
chr6_111197567_111198255 | 1.08 |
AMD1 |
adenosylmethionine decarboxylase 1 |
1133 |
0.45 |
chr16_4852580_4852899 | 1.07 |
ROGDI |
rogdi homolog (Drosophila) |
111 |
0.93 |
chr1_160680341_160680580 | 1.07 |
CD48 |
CD48 molecule |
1133 |
0.45 |
chr6_143189309_143189460 | 1.07 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
31200 |
0.22 |
chr20_56007880_56008044 | 1.07 |
RP4-800J21.3 |
|
39844 |
0.12 |
chr19_46389727_46390064 | 1.06 |
IRF2BP1 |
interferon regulatory factor 2 binding protein 1 |
519 |
0.64 |
chr12_123559968_123560341 | 1.05 |
PITPNM2 |
phosphatidylinositol transfer protein, membrane-associated 2 |
488 |
0.8 |
chr3_9404758_9405450 | 1.05 |
RP11-380O24.1 |
|
117 |
0.75 |
chr4_89534455_89534711 | 1.05 |
HERC3 |
HECT and RLD domain containing E3 ubiquitin protein ligase 3 |
7638 |
0.19 |
chr5_118678013_118678296 | 1.05 |
TNFAIP8 |
tumor necrosis factor, alpha-induced protein 8 |
9284 |
0.21 |
chr1_16023616_16024163 | 1.05 |
ENSG00000264048 |
. |
12922 |
0.1 |
chr4_147096724_147097114 | 1.05 |
LSM6 |
LSM6 homolog, U6 small nuclear RNA associated (S. cerevisiae) |
38 |
0.98 |
chr3_59996849_59997073 | 1.05 |
NPCDR1 |
nasopharyngeal carcinoma, down-regulated 1 |
39378 |
0.24 |
chr8_23416478_23416629 | 1.04 |
AC051642.1 |
|
4098 |
0.19 |
chr22_40728342_40728493 | 1.04 |
ADSL |
adenylosuccinate lyase |
14090 |
0.18 |
chr15_79123106_79123257 | 1.04 |
ADAMTS7 |
ADAM metallopeptidase with thrombospondin type 1 motif, 7 |
19408 |
0.16 |
chr19_22034889_22035210 | 1.04 |
ZNF43 |
zinc finger protein 43 |
122 |
0.98 |
chrX_1780511_1780662 | 1.04 |
ASMT |
acetylserotonin O-methyltransferase |
25295 |
0.22 |
chr3_150864631_150864782 | 1.04 |
ENSG00000199994 |
. |
41180 |
0.13 |
chr2_25545861_25546012 | 1.03 |
ENSG00000221445 |
. |
5654 |
0.23 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 6.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.9 | 5.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.6 | 0.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.5 | 1.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.5 | 1.6 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.5 | 1.9 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.4 | 0.9 | GO:0060426 | lung vasculature development(GO:0060426) |
0.4 | 0.4 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.4 | 1.9 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.4 | 1.5 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.4 | 1.1 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.3 | 1.0 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.3 | 1.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 1.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.3 | 2.0 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.3 | 0.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.3 | 0.9 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 0.9 | GO:0070828 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.3 | 2.1 | GO:0007172 | signal complex assembly(GO:0007172) |
0.3 | 0.9 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.3 | 1.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 0.9 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 | 0.3 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.3 | 1.1 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.3 | 1.1 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.3 | 1.1 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.3 | 1.1 | GO:0031342 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) negative regulation of cell killing(GO:0031342) |
0.3 | 1.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.3 | 1.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.3 | 1.3 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.3 | 1.0 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.2 | 1.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 1.2 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.2 | 0.9 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.2 | 0.9 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 1.6 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.2 | 0.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.4 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.2 | 0.9 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 1.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.2 | 0.4 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.2 | 0.6 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.2 | 0.6 | GO:0045628 | T-helper 2 cell differentiation(GO:0045064) regulation of T-helper 2 cell differentiation(GO:0045628) |
0.2 | 0.2 | GO:0016064 | immunoglobulin mediated immune response(GO:0016064) |
0.2 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 1.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 1.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 0.6 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 0.6 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 0.6 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.2 | 0.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.4 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.2 | 1.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.5 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.2 | 0.9 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 1.4 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 0.5 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 0.7 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 0.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.2 | 0.7 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.2 | 0.9 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.2 | 0.7 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.2 | 2.0 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.3 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.2 | 0.5 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.2 | 0.5 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.2 | 0.3 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.8 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.2 | 1.5 | GO:0048194 | COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.2 | 0.7 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 0.6 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 1.0 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.2 | 0.2 | GO:0046084 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.2 | 0.5 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 1.6 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 0.2 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.2 | 0.5 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.2 | 2.4 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 1.3 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.4 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.1 | 0.1 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.1 | 0.4 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 2.4 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.4 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 1.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.8 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.3 | GO:2000644 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.1 | 1.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 1.3 | GO:1903078 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.1 | GO:1902622 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.1 | 2.1 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.5 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.1 | 0.5 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 0.5 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.4 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.6 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.5 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.5 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.6 | GO:0043368 | positive T cell selection(GO:0043368) |
0.1 | 1.0 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.3 | GO:0032048 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 4.8 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 1.1 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 1.4 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.2 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.5 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 | 0.3 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.1 | 0.4 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.4 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.3 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.8 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 1.9 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.7 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.3 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 1.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.3 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.3 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.1 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.1 | 0.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.5 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.9 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 1.5 | GO:0075733 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.1 | 0.4 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.1 | 0.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.3 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.1 | 0.3 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.3 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.5 | GO:0007549 | dosage compensation(GO:0007549) |
0.1 | 0.1 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.1 | 1.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 1.6 | GO:0034620 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
0.1 | 0.7 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.8 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.2 | GO:0048143 | astrocyte activation(GO:0048143) |
0.1 | 0.3 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.2 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.1 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.5 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.2 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.1 | 0.5 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.6 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.7 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.1 | 0.1 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.1 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.4 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 1.9 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.6 | GO:0072283 | mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003337) mesenchymal to epithelial transition(GO:0060231) metanephric renal vesicle morphogenesis(GO:0072283) |
0.1 | 2.6 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.1 | 0.3 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.1 | 0.6 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.1 | 0.1 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.1 | 0.3 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0052169 | microglial cell activation involved in immune response(GO:0002282) pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response(GO:0052033) positive regulation by symbiont of host innate immune response(GO:0052166) modulation by symbiont of host innate immune response(GO:0052167) pathogen-associated molecular pattern dependent modulation by symbiont of host innate immune response(GO:0052169) pathogen-associated molecular pattern dependent induction by organism of innate immune response of other organism involved in symbiotic interaction(GO:0052257) positive regulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052305) modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052306) pathogen-associated molecular pattern dependent modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052308) positive regulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052555) positive regulation by symbiont of host immune response(GO:0052556) |
0.1 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.3 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.5 | GO:0039694 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.1 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.1 | 0.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.3 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 9.2 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.3 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.1 | 0.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.1 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 0.2 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 1.5 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.2 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.1 | 1.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.2 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.1 | GO:0090075 | relaxation of muscle(GO:0090075) |
0.1 | 0.1 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.1 | 1.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 5.8 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.2 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.4 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.2 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.2 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.1 | 0.3 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.1 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.4 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.1 | 0.2 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 1.5 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.1 | 0.1 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 2.0 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.1 | 0.2 | GO:0018210 | peptidyl-threonine modification(GO:0018210) |
0.1 | 0.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.3 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.1 | 0.9 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.5 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 1.0 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 0.3 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.4 | GO:0045830 | positive regulation of isotype switching(GO:0045830) positive regulation of DNA recombination(GO:0045911) |
0.1 | 0.7 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 1.1 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 0.1 | GO:0051322 | anaphase(GO:0051322) |
0.1 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 3.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.2 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.2 | GO:0034728 | nucleosome organization(GO:0034728) |
0.1 | 0.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 1.0 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:0032682 | negative regulation of chemokine production(GO:0032682) negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 0.2 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.1 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.1 | 0.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.3 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.1 | GO:0003079 | maternal aggressive behavior(GO:0002125) obsolete positive regulation of natriuresis(GO:0003079) |
0.1 | 0.1 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.1 | 0.1 | GO:0044415 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.7 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.1 | 0.3 | GO:0033363 | secretory granule organization(GO:0033363) |
0.1 | 0.1 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.1 | 1.8 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.1 | 0.3 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.1 | GO:0001821 | histamine secretion(GO:0001821) |
0.1 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.1 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.1 | 0.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.5 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.3 | GO:0090398 | cellular senescence(GO:0090398) |
0.1 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.3 | GO:0007004 | telomere maintenance via telomerase(GO:0007004) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.1 | GO:0001845 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.1 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.9 | GO:0007031 | peroxisome organization(GO:0007031) |
0.1 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.2 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.3 | GO:0042119 | granulocyte activation(GO:0036230) neutrophil activation(GO:0042119) |
0.1 | 0.1 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.1 | GO:0051136 | NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.2 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.1 | 0.1 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.1 | 0.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.2 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.1 | GO:0043247 | telomere capping(GO:0016233) protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 1.0 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.1 | GO:0002645 | regulation of tolerance induction(GO:0002643) positive regulation of tolerance induction(GO:0002645) |
0.1 | 2.6 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 0.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.1 | GO:0003159 | endocardium development(GO:0003157) morphogenesis of an endothelium(GO:0003159) endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.1 | 0.4 | GO:0071326 | cellular response to monosaccharide stimulus(GO:0071326) cellular response to hexose stimulus(GO:0071331) cellular response to glucose stimulus(GO:0071333) |
0.1 | 0.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.2 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.4 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.4 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 1.0 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.1 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.1 | 0.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.2 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 1.8 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.1 | 0.1 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.1 | 0.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.9 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.1 | GO:0032944 | regulation of mononuclear cell proliferation(GO:0032944) |
0.1 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.1 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) |
0.1 | 0.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.6 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.5 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.8 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.1 | 1.3 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.3 | GO:0007159 | leukocyte cell-cell adhesion(GO:0007159) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.4 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 1.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.7 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.1 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.3 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.0 | 0.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.3 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.0 | GO:0048569 | post-embryonic organ morphogenesis(GO:0048563) post-embryonic organ development(GO:0048569) |
0.0 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 1.8 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.1 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.0 | 0.0 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.1 | GO:0015879 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.0 | 0.0 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.1 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.0 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.0 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
0.0 | 2.0 | GO:0006909 | phagocytosis(GO:0006909) |
0.0 | 1.0 | GO:0001709 | cell fate determination(GO:0001709) |
0.0 | 0.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.0 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 4.1 | GO:0046649 | lymphocyte activation(GO:0046649) |
0.0 | 0.8 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 1.4 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.0 | 0.1 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 2.3 | GO:0000087 | mitotic M phase(GO:0000087) |
0.0 | 0.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.0 | 0.1 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.2 | GO:0010042 | response to manganese ion(GO:0010042) |
0.0 | 0.1 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
0.0 | 0.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.1 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.0 | 0.2 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.0 | 0.0 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.0 | 0.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.0 | 0.3 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.1 | GO:0051900 | regulation of membrane depolarization(GO:0003254) regulation of mitochondrial depolarization(GO:0051900) |
0.0 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 4.8 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.2 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.2 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.1 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 1.9 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.0 | 0.0 | GO:1902337 | regulation of apoptotic process involved in morphogenesis(GO:1902337) regulation of apoptotic process involved in development(GO:1904748) |
0.0 | 0.0 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.0 | 0.1 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.0 | 0.1 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.0 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.0 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.0 | 0.4 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.0 | 0.0 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.1 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.6 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.3 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.0 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.0 | 0.5 | GO:0051693 | actin filament capping(GO:0051693) |
0.0 | 0.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.3 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.2 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.2 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.0 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.6 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.2 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.1 | GO:0006490 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.4 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 0.8 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.0 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.0 | 0.3 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.5 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
0.0 | 0.5 | GO:0045453 | bone resorption(GO:0045453) |
0.0 | 0.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.1 | GO:0031054 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) pre-miRNA processing(GO:0031054) |
0.0 | 0.1 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.1 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.0 | 0.0 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.3 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.0 | 0.2 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.0 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.0 | 0.0 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.1 | GO:0060872 | semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
0.0 | 0.4 | GO:0019079 | viral genome replication(GO:0019079) |
0.0 | 0.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.0 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 9.1 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) cellular response to ammonium ion(GO:0071242) acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.3 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.1 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.1 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.0 | 0.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.0 | 0.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.0 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.1 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.6 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.5 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.4 | GO:0009988 | binding of sperm to zona pellucida(GO:0007339) cell-cell recognition(GO:0009988) sperm-egg recognition(GO:0035036) |
0.0 | 0.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 2.9 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.0 | 0.1 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.0 | 0.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.1 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.2 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.3 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.0 | 0.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.1 | GO:0048668 | collateral sprouting(GO:0048668) regulation of collateral sprouting(GO:0048670) |
0.0 | 0.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 1.5 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.1 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.7 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.1 | GO:0072665 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.8 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.6 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.1 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.0 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.0 | 0.6 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.0 | 0.0 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 0.0 | GO:0052509 | modulation by symbiont of host defense response(GO:0052031) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.0 | 0.0 | GO:0000239 | pachytene(GO:0000239) |
0.0 | 0.1 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.0 | 0.1 | GO:1904376 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.0 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 6.1 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.1 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.0 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.0 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.4 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.0 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.2 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.0 | 0.2 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
0.0 | 1.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.2 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.0 | 0.1 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.0 | 0.0 | GO:0010821 | regulation of mitochondrion organization(GO:0010821) |
0.0 | 1.0 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.0 | 1.0 | GO:0006914 | autophagy(GO:0006914) |
0.0 | 2.1 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.0 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.0 | 0.0 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.0 | 0.2 | GO:0006101 | tricarboxylic acid cycle(GO:0006099) citrate metabolic process(GO:0006101) tricarboxylic acid metabolic process(GO:0072350) |
0.0 | 0.5 | GO:0044728 | DNA methylation or demethylation(GO:0044728) |
0.0 | 0.1 | GO:0043137 | lagging strand elongation(GO:0006273) DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.0 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.4 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.0 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.3 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.0 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.0 | 1.1 | GO:0009156 | ribonucleoside monophosphate biosynthetic process(GO:0009156) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.0 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:0042267 | natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.3 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.0 | 0.0 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.0 | 0.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.0 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.0 | 0.0 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.0 | 0.2 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.0 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.6 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.0 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.0 | 0.0 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.0 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.8 | GO:0009135 | purine nucleoside diphosphate metabolic process(GO:0009135) purine ribonucleoside diphosphate metabolic process(GO:0009179) ribonucleoside diphosphate metabolic process(GO:0009185) ADP metabolic process(GO:0046031) |
0.0 | 0.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.0 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.0 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.1 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.0 | 0.0 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.5 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 2.6 | GO:0016568 | chromatin modification(GO:0016568) |
0.0 | 0.1 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
0.0 | 0.1 | GO:0046034 | ATP metabolic process(GO:0046034) |
0.0 | 0.0 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.0 | 0.0 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.0 | 0.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.5 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.0 | 0.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.0 | 0.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.0 | GO:0071503 | response to heparin(GO:0071503) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 1.4 | GO:0044772 | mitotic cell cycle phase transition(GO:0044772) |
0.0 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.0 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.2 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.0 | 0.0 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.0 | 0.9 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.2 | GO:0001906 | cell killing(GO:0001906) |
0.0 | 0.0 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.0 | 0.2 | GO:0015992 | hydrogen transport(GO:0006818) proton transport(GO:0015992) |
0.0 | 0.2 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.0 | 0.0 | GO:0007418 | ventral midline development(GO:0007418) |
0.0 | 0.4 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.3 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.0 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.0 | 0.0 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.2 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.0 | 0.0 | GO:1903299 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.4 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.0 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 4.5 | GO:0006955 | immune response(GO:0006955) |
0.0 | 0.2 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.0 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.1 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.0 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.3 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.2 | GO:0033865 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.0 | 0.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.0 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.0 | 0.2 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.0 | 0.0 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.0 | 0.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.0 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.0 | 0.1 | GO:0042455 | ribonucleoside biosynthetic process(GO:0042455) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.0 | GO:0001705 | ectoderm formation(GO:0001705) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.8 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.0 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.4 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.0 | 0.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.3 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 0.0 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.0 | GO:0070293 | renal absorption(GO:0070293) |
0.0 | 0.0 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.1 | GO:0007051 | spindle organization(GO:0007051) |
0.0 | 0.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) cellular response to amino acid stimulus(GO:0071230) |
0.0 | 0.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.0 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.0 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.0 | 0.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.0 | 0.0 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 0.0 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.0 | 0.2 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.1 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
0.0 | 0.0 | GO:0000718 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.0 | 0.0 | GO:1903307 | positive regulation of regulated secretory pathway(GO:1903307) |
0.0 | 0.0 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.0 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 0.0 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.0 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.0 | 0.0 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.0 | GO:0001820 | serotonin secretion(GO:0001820) |
0.0 | 0.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.0 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.0 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.0 | 0.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.0 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.0 | 0.0 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.0 | 0.1 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.1 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.0 | 0.0 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.5 | GO:0043038 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.0 | 0.1 | GO:0045008 | depyrimidination(GO:0045008) |
0.0 | 0.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.0 | 0.6 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.0 | GO:0051917 | regulation of fibrinolysis(GO:0051917) |
0.0 | 0.0 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.0 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.4 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 0.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.0 | GO:0051647 | nucleus localization(GO:0051647) |
0.0 | 0.3 | GO:0007346 | regulation of mitotic cell cycle(GO:0007346) |
0.0 | 0.0 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.1 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.0 | 0.4 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 0.3 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.1 | GO:0000084 | mitotic S phase(GO:0000084) |
0.0 | 1.1 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.1 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.0 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.0 | 0.1 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.0 | 0.0 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.0 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.0 | 0.1 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.0 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.0 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.0 | 0.0 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.0 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 3.6 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.4 | 3.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 0.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 1.4 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 1.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.3 | 2.0 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 4.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 0.9 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 1.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 0.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 1.2 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.9 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 1.3 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 2.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 2.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 1.2 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.2 | 1.0 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 1.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 1.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 2.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.5 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 1.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.6 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 1.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 2.9 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.5 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.8 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 1.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.6 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 1.7 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.2 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.1 | 0.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 1.1 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.4 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 1.0 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 1.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 1.5 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 1.0 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.3 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 1.0 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.4 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.1 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.6 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 2.0 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 2.3 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 2.1 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.1 | 5.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.5 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 1.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 5.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 1.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 2.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.3 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.2 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.1 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.9 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 1.2 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 1.6 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 2.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.3 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 1.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 1.0 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.3 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.1 | 2.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.3 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.4 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.2 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.5 | GO:1904949 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.0 | 0.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 0.8 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.0 | 0.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 2.6 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 2.2 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.0 | GO:0044452 | nucleolar part(GO:0044452) |
0.0 | 0.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.6 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.0 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.2 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 1.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 1.5 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.7 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 1.0 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.0 | 0.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.3 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 4.1 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.0 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 5.5 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 1.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 1.3 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.2 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 1.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.2 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.3 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.0 | 0.1 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.2 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.0 | 0.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 0.0 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.2 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.0 | 0.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 3.6 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.2 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.0 | 0.0 | GO:0009295 | nucleoid(GO:0009295) |
0.0 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.8 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.2 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 2.0 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.4 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 4.7 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.0 | 0.1 | GO:0090568 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 0.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 40.4 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 1.0 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 1.1 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.1 | GO:0030992 | intraciliary transport particle(GO:0030990) intraciliary transport particle B(GO:0030992) |
0.0 | 0.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.2 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.2 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) |
0.0 | 0.0 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 2.3 | GO:0098552 | side of membrane(GO:0098552) |
0.0 | 0.2 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.0 | GO:0001652 | granular component(GO:0001652) |
0.0 | 1.4 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.0 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.2 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 9.8 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 1.1 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.2 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 2.6 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 13.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.1 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 3.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.3 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.5 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.0 | 0.3 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.0 | 0.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.1 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.0 | 0.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 1.2 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.0 | GO:1902562 | H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.1 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 45.4 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.2 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.1 | GO:0031975 | envelope(GO:0031975) |
0.0 | 0.1 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.4 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 1.5 | GO:0000139 | Golgi membrane(GO:0000139) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.6 | 4.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.6 | 1.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.6 | 1.8 | GO:0043398 | HLH domain binding(GO:0043398) |
0.6 | 1.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.4 | 1.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.4 | 1.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 1.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.3 | 0.9 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.3 | 0.9 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.3 | 0.9 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.3 | 1.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 0.8 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 1.6 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.3 | 0.8 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.3 | 1.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 0.8 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 0.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 2.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.2 | 0.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 1.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.6 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.2 | 0.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 0.8 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 0.4 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.2 | 0.8 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.6 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 1.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 2.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.2 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.2 | 1.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 1.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 1.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 0.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 1.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 1.7 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.2 | 5.1 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.2 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.2 | 0.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 1.2 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.4 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.9 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 1.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 2.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.4 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 2.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.5 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 0.4 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.4 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 0.5 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 1.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.8 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 1.1 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 1.6 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.1 | 0.4 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 1.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 1.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 1.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.5 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.1 | 0.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 1.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.9 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 4.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 1.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.4 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.1 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.3 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 1.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.1 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 1.3 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.1 | 0.3 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 2.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.2 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.1 | 0.6 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 0.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.3 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.2 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 1.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.1 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.1 | 0.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.5 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.1 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.1 | 0.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 1.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.2 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.1 | 0.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.4 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 2.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.4 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 2.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 1.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.3 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 2.1 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 3.5 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 1.4 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 2.2 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.8 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 0.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.2 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.1 | 0.8 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.3 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.2 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 4.1 | GO:0044389 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 0.3 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.3 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.1 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.1 | 0.2 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.5 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 1.4 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.7 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 1.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 3.1 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.2 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.9 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.4 | GO:0004931 | purinergic nucleotide receptor activity(GO:0001614) extracellular ATP-gated cation channel activity(GO:0004931) nucleotide receptor activity(GO:0016502) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.5 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 0.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 1.4 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.0 | 1.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.0 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 0.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.7 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 1.4 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.0 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.0 | 0.3 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.1 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.7 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.1 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.2 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 0.2 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.1 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.0 | 0.2 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.3 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 2.6 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.0 | 0.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.1 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 11.5 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.0 | 0.1 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.8 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.0 | 0.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.0 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 1.2 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.0 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 1.5 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 4.6 | GO:0010843 | obsolete promoter binding(GO:0010843) |
0.0 | 0.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.1 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.0 | 0.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.7 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.3 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 3.2 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 4.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 9.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 1.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.0 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 2.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 1.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.4 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.1 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.0 | 0.4 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.0 | 1.0 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.1 | GO:0061659 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.9 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.2 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.8 | GO:0050136 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.0 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 2.3 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 2.7 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 2.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.2 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.0 | 0.0 | GO:0046970 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.0 | 0.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 2.2 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.8 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.0 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.0 | 0.1 | GO:0008106 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 0.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 10.0 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.5 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.0 | 0.4 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.1 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.1 | GO:0016803 | epoxide hydrolase activity(GO:0004301) hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
0.0 | 0.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.0 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.0 | 0.0 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.0 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.9 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 0.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 33.5 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.0 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.2 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.5 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 0.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.6 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.2 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 0.2 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.0 | 0.2 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.5 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.0 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.5 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 3.2 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.0 | 0.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.0 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.4 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.0 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.2 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.0 | GO:0004396 | hexokinase activity(GO:0004396) |
0.0 | 0.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.0 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.0 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.1 | GO:0048029 | monosaccharide binding(GO:0048029) |
0.0 | 0.0 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 1.8 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.0 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.0 | 0.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.0 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.0 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.0 | 0.0 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.3 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0003924 | GTPase activity(GO:0003924) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 8.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 10.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 6.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 1.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 3.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 7.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 2.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 3.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 2.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.8 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 2.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 2.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 1.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 3.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 3.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 0.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 1.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 2.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 1.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 1.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.2 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 1.6 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 1.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 1.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 1.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.5 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.8 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 2.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 1.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 1.2 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.0 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 2.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.1 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.0 | PID IFNG PATHWAY | IFN-gamma pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.3 | 6.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 0.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 1.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 2.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 3.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 3.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 1.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 2.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 0.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 1.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 1.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 1.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 2.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 1.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 1.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 1.8 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 2.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 1.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.0 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 2.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 1.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.2 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 1.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 2.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 0.5 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 2.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 1.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 5.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 2.6 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 1.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 2.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 2.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 4.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.7 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 2.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 3.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 3.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 6.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.7 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 1.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 0.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 1.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 1.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.6 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 1.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 1.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 2.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.1 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.1 | 0.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.1 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 0.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 1.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 1.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.4 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.0 | 0.1 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.0 | 0.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 3.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 1.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 1.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.2 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 1.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.1 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.0 | 0.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 1.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 1.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 3.2 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.5 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 2.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 1.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 2.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 1.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.0 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.0 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.1 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.0 | 0.8 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 1.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.9 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 3.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 1.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 5.2 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.3 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.4 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.0 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.0 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.0 | 0.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.2 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.0 | 0.1 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.2 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.0 | 0.1 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.2 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.0 | 0.0 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.0 | 0.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.2 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.2 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.0 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.0 | 1.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |